Der Test kann nicht Corona und Grippe unterscheiden

  • Ganz beiläufig im Juli 2021 sagt das CDC (das amerikanische RKI), dass es dem Drosten Test die Notzulassung Ende 2021 entziehen wird.
  • Es regt Hersteller an neue Test zu entwickeln, die eben auch Corona und die Grippe unterscheiden können
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing